Two adolescent cases of acute tubulointerstitial nephritis after second dose of COVID-19 mRNA vaccine

The Food and Drug Administration (FDA) expanded the emergency use authorization for the BNT162b2 messenger RNA (mRNA) vaccine (Pfizer–BioNTech) for children aged 12–15 years on 10 May 2021. To date, less than a year has passed since vaccination against COVID-19 has been used in children and adolesce...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jae Hong, Kang, Ki-Soo, Han, Kyoung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897634/
https://www.ncbi.nlm.nih.gov/pubmed/35385678
http://dx.doi.org/10.1080/21645515.2022.2059308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897634/
https://www.ncbi.nlm.nih.gov/pubmed/35385678
http://dx.doi.org/10.1080/21645515.2022.2059308

Ejemplares similares